La Organizacin Mundial de la Salud ha incluido los frmacos GLP-1 para tratar la diabetes en su lista de medicamentos esenciales, junto con los tratamientos para la fibrosis qustica y el cncer, y espera que esto ayude a mejorar el acceso mundial a estos costosos medicamentos
doi:10.1007/s44192-022-00027-w 87
As drug formularies have become more intricate, many firms have minimum and maximums attached to their copays and coinsurances, leading us to believe it was no longer appropriate to assume that a firms cost sharing followed this sequential logic
McDonald's took a 3.6% hit in U.S
For patients still on GLP-1 therapy, the protocol is a long-term commitment because the medication's effects are ongoing
Overall, DPP4i have a favourable therapeutic profile and are safe and effective in the majority of patients with type 2 diabetes mellitus